Literature DB >> 8623750

Clinical impact of transcatheter closure of secundum atrial septal defects with the double umbrella device.

R N Justo1, D G Nykanen, C Boutin, B W McCrindle, R M Freedom, L N Benson.   

Abstract

The clinical impact of transcatheter closure of the isolated secundum atrial septal defect was reviewed. Closure by echocardiographic evaluation was 23 +/- 14% at 6 months, 49 +/- 16% at 2 years, and 64 +/- 16% at 4 years, and right ventricular end-diastolic dimensions in patients without residual shunts did not differ significantly from those with residual shunts.

Entities:  

Mesh：

Year:  1996        PMID： 8623750     DOI： 10.1016/S0002-9149(97)89192-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  3 in total

1.  Transcatheter closure of atrial septal defects using the Cardio-Seal implant.

Authors:  C A Pedra; J Pihkala; K J Lee; C Boutin; D G Nykanen; P R McLaughlin; D A Harrison; R M Freedom; L Benson
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

2.  Extending the limits of transcatheter closure of atrial septal defects with the double umbrella device (CardioSEAL).

Authors:  R Kaulitz; T Paul; G Hausdorf
Journal:  Heart       Date:  1998-07       Impact factor: 5.994

3.  Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients.

Authors:  G Fischer; J Stieh; A Uebing; U Hoffmann; G Morf; H H Kramer
Journal:  Heart       Date:  2003-02       Impact factor: 5.994
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.